Literature DB >> 23925442

Mechanisms for cachexia in heart failure.

Vincent Pureza1, Viorel G Florea.   

Abstract

The combination of profound muscle wasting and severe weight loss that occurs in heart failure is a complex phenomenon that involves the interplay of numerous factors. In this article, we describe processes that contribute to cachexia, as part of the clinical sequelae of heart failure, and their potential underlying mechanisms. While multiple mechanisms of cardiac cachexia have been described, we propose a multifactorial etiology for this condition that includes, but is not limited to, nutritional and gastrointestinal alterations, immunological and neurohormonal activation, and anabolic and catabolic imbalance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925442     DOI: 10.1007/s11897-013-0153-9

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  93 in total

1.  Oxpentifylline in endotoxaemia.

Authors:  P Zabel; D T Wolter; M M Schönharting; U F Schade
Journal:  Lancet       Date:  1989 Dec 23-30       Impact factor: 79.321

2.  Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

Authors:  J Niebauer; H D Volk; M Kemp; M Dominguez; R R Schumann; M Rauchhaus; P A Poole-Wilson; A J Coats; S D Anker
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

3.  Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

Authors:  A Deswal; N J Petersen; A M Feldman; J B Young; B G White; D L Mann
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

4.  Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors:  K Tatemoto; M Carlquist; V Mutt
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.

Authors:  L Liu; S P Zhao
Journal:  Int J Cardiol       Date:  1999-04-30       Impact factor: 4.164

6.  Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.

Authors:  Noritoshi Nagaya; Junji Moriya; Yoshio Yasumura; Masaaki Uematsu; Fumiaki Ono; Wataru Shimizu; Kazuyuki Ueno; Masafumi Kitakaze; Kunio Miyatake; Kenji Kangawa
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

7.  Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

Authors:  K J Osterziel; O Strohm; J Schuler; M Friedrich; D Hänlein; R Willenbrock; S D Anker; P A Poole-Wilson; M B Ranke; R Dietz
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

Review 8.  Growth hormone resistance in chronic heart failure and its therapeutic implications.

Authors:  Mariantonietta Cicoira; Paul R Kalra; Stefan D Anker
Journal:  J Card Fail       Date:  2003-06       Impact factor: 5.712

9.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

10.  Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction.

Authors:  Ramachandran S Vasan; Alexa Beiser; Ralph B D'Agostino; Daniel Levy; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Peter W F Wilson
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272

View more
  16 in total

Review 1.  A heart-adipose tissue connection in the regulation of energy metabolism.

Authors:  Sheila Collins
Journal:  Nat Rev Endocrinol       Date:  2013-12-03       Impact factor: 43.330

Review 2.  Frailty in heart failure.

Authors:  Izabella Uchmanowicz; Maria Łoboz-Rudnicka; Przemysław Szeląg; Beata Jankowska-Polańska; Krystyna Łoboz-Grudzień
Journal:  Curr Heart Fail Rep       Date:  2014-09

3.  No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy.

Authors:  Chesney D Castleberry; John L Jefferies; Ling Shi; James D Wilkinson; Jeffrey A Towbin; Ryan W Harrison; Joseph W Rossano; Elfriede Pahl; Teresa M Lee; Linda J Addonizio; Melanie D Everitt; Justin Godown; Joseph Mahgerefteh; Paolo Rusconi; Charles E Canter; Steven D Colan; Paul F Kantor; Hiedy Razoky; Steven E Lipshultz; Tracie L Miller
Journal:  JACC Heart Fail       Date:  2018-02-07       Impact factor: 12.035

Review 4.  Review of nutritional screening and assessment tools and clinical outcomes in heart failure.

Authors:  Hong Lin; Haifeng Zhang; Zheng Lin; Xinli Li; Xiangqin Kong; Gouzhen Sun
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 5.  Publication trends in cachexia and sarcopenia in elderly heart failure patients.

Authors:  Jochen Springer; Stefan D Anker
Journal:  Wien Klin Wochenschr       Date:  2016-11-24       Impact factor: 1.704

6.  New Approaches to Treating Cardiac Cachexia in the Older Patient.

Authors:  Gohar Azhar; Jeanne Y Wei
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

7.  Impact of Melatonin and Branched-Chain Amino Acids Cosupplementation on Quality of Life, Fatigue, and Nutritional Status in Cachectic Heart Failure Patients: A Randomized Controlled Trial.

Authors:  Hamed Jafari-Vayghan; Jalal Moludi; Sevda Saleh-Ghadimi; Elgar Enamzadeh; Mir Hossein Seyed-Mohammadzad; Mohammad Alizadeh
Journal:  Am J Lifestyle Med       Date:  2019-09-14

8.  Weight Loss in Obese Patients With Heart Failure.

Authors:  Elisabet Zamora; Carles Díez-López; Josep Lupón; Marta de Antonio; Mar Domingo; Javier Santesmases; María Isabel Troya; Crisanto Díez-Quevedo; Salvador Altimir; Antoni Bayes-Genis
Journal:  J Am Heart Assoc       Date:  2016-03-24       Impact factor: 5.501

9.  Long-term mortality in older patients discharged after acute decompensated heart failure: a prospective cohort study.

Authors:  Pierre-André Natella; Philippe Le Corvoisier; Elena Paillaud; Bertrand Renaud; Isabelle Mahé; Jean-François Bergmann; Hervé Perchet; Dominique Mottier; Olivier Montagne; Sylvie Bastuji-Garin
Journal:  BMC Geriatr       Date:  2017-01-26       Impact factor: 3.921

10.  Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure.

Authors:  Piotr Rozentryt; Jacek T Niedziela; Bartosz Hudzik; Andrzej Lekston; Wolfram Doehner; Ewa A Jankowska; Jolanta Nowak; Stephan von Haehling; Robert Partyka; Tomasz Rywik; Stefan D Anker; Piotr Ponikowski; Lech Poloński
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-22       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.